Loss of SMARCB1 (the human Snr1 homolog) is the hallmark genetic alteration leading to atypical teratoid rhabdoid tumours (AT/RT), which are highly aggressive central nervous system tumours affecting infants and young children (Frühwald et al., 2016). The gene discussed is SMARCB1; the disease is ataxia telangiectasia.